Loyal dog found after waiting weeks next to home burned down by Camp Fire in California
A month after losing their house in the Camp Fire, the homeowners were brought to tears when Madison, an Anatolian shepherd, was found alive and well -- protecting “what was left of his home.” Over a month ago, Madison’s owner, Andrea Gaylord, was not able to get back the home after the Camp Fire forced evacuations and she had to leave him and his brother Miguel at the house. >> Read more trending news Gaylord told KXTV that she believed that Madison had survived the fire. Shayla Sullivan located Miguel earlier in neighboring Citrus Heights and asked to use an article of clothing belonging to Gaylord to leave on the now burned out property hoping that Madison would pick up the scent. She said the dog was apprehensive and kept his distance. “I had the idea of placing an article of clothing that would smell like her to keep Madison's hope alive until his people could return,” Sullivan wrote on Facebook. When Gaylord was finally able to return to where her home once stood, she found Madison there waiting for her. 'Imagine the loyalty of hanging in in the worst of circumstances and being here waiting. It was so emotional,' Gaylord told KXTV. Though Gaylord lost her home in the fire, Miguel and Madision are back at her side. 'He had stayed to protect what was left of his home, and NEVER gave up on his people!' Sullivan wrote in a Facebook post Wednesday. At least 1,643 buildings, most of them homes, were destroyed in the Camp Fire, the worst wildfire in the history of California.
More blood pressure medication recalled due to possible cancer risk
Yet another blood pressure medication has been added to the list of recalled hypertension drugs. >> On AJC.com: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say Mylan Pharmaceuticals has voluntarily expanded its recall for its valsartan-containing products, the U.S. Food and Drug Administration announced. The affected pills include valsartan, amlodipine/valsartan and valsartan/hydrochlorothiazide tablets and were distributed in the United States between March 2017 and November 2018. The FDA has listed additional information about the specifics, including doses, lot numbers and expiration dates, on its site. >> Read more trending news According to the press release, the drugs contain traces of N-nitroso-diethylamine (NDEA). The impurity, typically found in certain foods, drinking water and air pollution, has been classified as a human carcinogen by the International Agency for Research on Cancer. Mylan is notifying its distributors and customers by letter and is arranging for the return of all recalled products. It is also coordinating returns with retailers, wholesalers and consumers. Patients on the medications are advised to continue taking the tablets and to contact their doctor for advice. The company said, “the risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any comparable alternative treatment.” The agency recently recalled several other blood pressure medications due to cancer concerns, and another was recalled for mislabeling. >> On AJC.com: Yet another blood pressure medication recalled over cancer risk Read the full FDA announcement at FDA.gov.
